Intelligent Investor

Bionomics Limited (ASX: BNO) - Announcements

DELISTED - Current share price for BNO : $0.010

ASX company news and announcements for Bionomics Limited (BNO) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bionomics Limited (BNO) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bionomics Limited (BNO), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bionomics Limited (BNO)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- 2022 AGM Results of Meeting 16 Nov 2022 2:49PM $0.068 $0.010 $0.010 fallen by 85.29%
- 2022 AGM Executive Chairman's Presentation 16 Nov 2022 10:04AM $0.068 $0.010 $0.010 fallen by 85.29%
- Corporate Presentation - November 2022 15 Nov 2022 9:56AM $0.068 $0.010 $0.010 fallen by 85.29%
- Proposed Underwritten Offering of ADS's in the US 15 Nov 2022 9:56AM $0.068 $0.010 $0.010 fallen by 85.29%
- Amendment of Form F-1 for Proposed Offering of ADS's in US 15 Nov 2022 9:56AM $0.068 $0.010 $0.010 fallen by 85.29%
- Trading Halt 15 Nov 2022 9:34AM $0.068 $0.010 $0.010 fallen by 85.29%
- Filing of Form F-1 for Proposed Offering of ADS's in the US 11 Nov 2022 10:29AM $0.070 $0.010 $0.010 fallen by 85.71%
- Quarterly Activities/Appendix 4C Cash Flow Report 25 Oct 2022 9:46AM $0.055 $0.010 $0.010 fallen by 81.82%
- R&D tax incentive refund for FY2022 received 18 Oct 2022 9:12AM $0.064 $0.010 $0.010 fallen by 84.38%
- Proposed issue of securities - BNO 17 Oct 2022 2:38PM $0.070 $0.010 $0.010 fallen by 85.71%
- BNO files Form 20-F with the SEC 17 Oct 2022 9:15AM $0.066 $0.010 $0.010 fallen by 84.85%
- 2022 Notice of AGM/Proxy Form 14 Oct 2022 9:19AM $0.066 $0.010 $0.010 fallen by 84.85%
- 2022 Corporate Governance Statement and Appendix 4G 6 Oct 2022 6:40PM $0.058 $0.010 $0.010 fallen by 82.76%
- 2022 Annual Report 6 Oct 2022 6:39PM $0.058 $0.010 $0.010 fallen by 82.76%
- Participation in Cantor Neurology & Psychiatry Conference 4 Oct 2022 6:04PM $0.061 $0.010 $0.010 fallen by 83.61%
- Corporate Presentation September 2022 29 Sep 2022 8:10AM $0.056 $0.010 $0.010 fallen by 82.14%
- Bionomics to Host KOL Webinar on BNC210 and SAD 21 Sep 2022 5:48PM $0.052 $0.010 $0.010 fallen by 80.77%
- Notification of cessation of securities - BNO 5 Sep 2022 12:17PM $0.051 $0.010 $0.010 fallen by 80.39%
- Bionomics reports Full Year Financial Results 30 June 2022 25 Aug 2022 3:01PM $0.052 $0.010 $0.010 fallen by 80.77%
- Appendix 4E and Full Year Financial Statements 30 June 2022 25 Aug 2022 2:59PM $0.052 $0.010 $0.010 fallen by 80.77%
- R&D tax incentive refund for FY2021 received 8 Aug 2022 8:04AM $0.052 $0.010 $0.010 fallen by 80.77%
- Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2022 5:19PM $0.051 $0.010 $0.010 fallen by 80.39%
- Notification regarding unquoted securities - BNO 20 Jul 2022 1:28PM $0.055 $0.010 $0.010 fallen by 81.82%
- Notification of cessation of securities - BNO 4 Jul 2022 1:24PM $0.055 $0.010 $0.010 fallen by 81.82%
- Ceasing to be a substantial holder 14 Jun 2022 12:21PM $0.055 $0.010 $0.010 fallen by 81.82%

51 - 75 of 801 results

Page 3 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.